US 12128102
Constrained conditionally activated binding proteins
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 12128102 (Constrained conditionally activated binding proteins) held by Takeda Pharmaceutical Company Limited expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61P, A61P35/00